To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
Condition: Gastric Cancer Interventions: Drug: Patients who continued UDCA 300mg medication; Other: Patients who discontinued UDCA 300mg prescription Sponsor: Daewoong Pharmaceutical Co. LTD. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2022 Category: Research Source Type: clinical trials